Two corporations are set to gain control of over 15% of New Zealand’s general practice market, including family doctors and primary healthcare services. In March, TPG, a US-based private equity firm, completed the acquisition of Tamaki Health, which encompasses 51 GP and urgent care clinics serving more than 230,000 registered patients, for approximately $450 million. Shortly after, health provider Tend announced its intention to purchase the medical division of Green Cross, which includes 65 clinics, for $270 million, pending a shareholder vote in July and approval from the Commerce Commission. The Commission is currently evaluating the competitive implications of the Tend-Green Cross deal but has not reported any significant concerns as of yet.
Why It Matters
The consolidation of healthcare services in New Zealand reflects a growing trend where private equity firms and tech-focused companies are increasingly investing in the healthcare sector. This trend raises concerns about the implications for healthcare accessibility and quality for the population, especially as more than 15% of general practice will be influenced by these two entities. Historically, New Zealand’s healthcare system has been predominantly publicly funded, and the shift towards private ownership may alter the landscape of primary healthcare delivery. The ongoing evaluations by regulatory bodies like the Commerce Commission will play a critical role in determining the future competitive environment of the healthcare market in New Zealand.
Want More Context? 🔎
